Skip to content

Advancements in Safe and Effective Injectable Treatment for Asthma

There are currently several injectable biologic treatments approved for use in severe asthma. The treatments are selected for patients based on their specific factors. Pharmacists need to be well-versed in all biologic treatments available to ensure that patients are treated with the most appropriate agent. Following this CE, pharmacists will be able to use the knowledge acquired to analyze the treatment regimens of their current patient population and assist with clinical decision making.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Explain the role of monoclonal antibodies in the treatment of severe asthma
  • Differentiate between biologic treatments for severe asthma
  • Identify which patients benefit from these injectable therapies
  • Compare characteristics of injectable therapies to determine which biologic is right for the patient
  • Identify important points to counsel on for administration of each product, to ensure patient safety

Presenter

Rebecca Williams, PharmD, is a PGY-1 community-Based Pharmacy Resident based in Massachusetts. She graduated from the Belmont University College of Pharmacy where she attained her PharmD in April 2021. During pharmacy school, she worked as a pharmacy intern for Walgreens in Nashville, TN.

Fellowship mentor: Matthew Machado, PharmD, Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences

Registration Fee: This module is provided free of charge.


Release Date: May 27, 2022
Expiration Date: May 26, 2023
ACPE UAN: 0026-0000-22-006-H01-P Knowledge
Topic Designator: Drug Therapy
Contact Hours: 1 (0. 1 CEU)

Accreditation

ACPE logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this activity for a total of 1.0 contact hour (0.1 CEU).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Rebecca Williams does not hold relevant financial relationships with ineligible companies.

Fellowship mentor, Matthew Machado, does not hold relevant financial relationships with ineligible companies.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.